On January 5, 2021 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, reported that management will provide an overview of the company’s business strategy and development-stage programs at three upcoming virtual investor conferences (Press release, Spectrum Pharmaceuticals, JAN 5, 2021, View Source [SID1234573466]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright BioConnect Conference, a fireside chat will be available on-demand through the conference portal and on the Spectrum corporate website beginning Monday, January 11th at 6 a.m. ET.
ICR Conference 2021, presentation, live webcast, Thursday, January 14th at 1:45 p.m. ET.
B. Riley Oncology Investor Conference, fireside chat, live webcast, Thursday, January 21st at 1 p.m. ET.
These events will be available from the Investor Relations section of the company’s website at View Source An archived webcast will be available shortly after the ICR and B. Riley live events from the same website location.